GlobeStar Therapeutics Corp Quarterly Common Stock, Shares, Issued from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
GlobeStar Therapeutics Corp quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q2 2024.
  • GlobeStar Therapeutics Corp Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 1.24B shares, a 42.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.24B +369M +42.3% Jun 30, 2024 10-Q 2024-10-11
Q1 2024 1.16B +382M +49% Mar 31, 2024 10-Q 2024-06-28
Q4 2023 1.05B +279M +36.3% Dec 31, 2023 10-Q 2024-03-12
Q3 2023 996M +274M +37.9% Sep 30, 2023 10-Q 2024-10-11
Q2 2023 872M +188M +27.5% Jun 30, 2023 10-Q 2023-08-17
Q1 2023 780M +175M +28.8% Mar 31, 2023 10-Q 2023-05-31
Q4 2022 770M +750M +3756% Dec 31, 2022 10-Q 2023-02-13
Q3 2022 722M +161M +28.6% Sep 30, 2022 10-K 2024-01-19
Q2 2022 684M +208M +43.5% Jun 30, 2022 10-Q/A 2022-08-23
Q1 2022 606M +130M +27.4% Mar 31, 2022 10-Q 2022-06-01
Q4 2021 20M -436M -95.6% Dec 31, 2021 10-K 2024-01-19
Q3 2021 561M 0 0% Sep 30, 2021 10-K 2023-01-09
Q2 2021 477M +93.7M +24.5% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 476M +171M +56.3% Mar 31, 2021 10-Q 2021-05-21
Q4 2020 455M +245M +117% Dec 31, 2020 10-Q 2021-01-28
Q3 2020 561M +391M +229% Sep 30, 2020 10-K 2022-01-05
Q2 2020 383M +274M +252% Jun 30, 2020 10-Q 2020-07-14
Q1 2020 304M +204M +204% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 210M +125M +147% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 170M +101M +146% Sep 30, 2019 10-K 2020-12-03
Q2 2019 109M +48.2M +79.5% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 100M +45.7M +83.6% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 85.1M +33M +63.4% Dec 31, 2018 10-Q 2019-02-19
Q3 2018 69.3M +23.7M +52.1% Sep 30, 2018 10-K 2019-12-31
Q2 2018 60.6M +19.5M +47.6% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 54.6M +16M +41.5% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 52.1M +14.8M +39.7% Dec 31, 2017 10-Q 2018-02-15
Q3 2017 45.6M +12.1M +36% Sep 30, 2017 10-K 2019-01-03
Q2 2017 41.1M +9.56M +30.3% Jun 30, 2017 10-Q/A 2017-08-23
Q1 2017 38.6M +28.6M +285% Mar 31, 2017 10-Q 2017-05-19
Q4 2016 37.3M +27.5M +283% Dec 31, 2016 10-Q 2017-04-10
Q3 2016 33.5M +24.7M +281% Sep 30, 2016 10-K 2018-01-16
Q2 2016 31.5M +31.1M +8403% Jun 30, 2016 10-Q/A 2016-09-16
Q1 2016 10M -23.7M -70.3% Mar 31, 2016 10-Q/A 2016-06-16
Q4 2015 9.74M -18.3M -65.2% Dec 31, 2015 10-Q 2016-02-22
Q3 2015 8.79M +8.54M +3332% Sep 30, 2015 10-Q/A 2016-06-16
Q2 2015 371K -20.4M -98.2% Jun 30, 2015 10-Q/A 2015-09-24
Q1 2015 33.7M +18.9M +128% Mar 31, 2015 10-Q/A 2015-09-17
Q4 2014 28M +14.9M +114% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 256K -10.6M -97.6% Sep 30, 2014 10-K/A 2016-01-22
Q2 2014 20.8M +11.5M +124% Jun 30, 2014 10-Q/A 2014-09-04
Q1 2014 14.8M +6.28M +73.5% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 13.1M +6.92M +112% Dec 31, 2013 10-Q/A 2014-02-21
Q3 2013 10.9M +5.22M +92.4% Sep 30, 2013 10-K/A 2015-01-27
Q2 2013 9.26M -4.44M -32.4% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 8.54M -3.46M -28.9% Mar 31, 2013 10-Q/A 2013-05-16
Q4 2012 6.2M -5.8M -48.4% Dec 31, 2012 10-Q/A 2013-03-07
Q3 2012 5.65M +5.05M +841% Sep 30, 2012 10-K/A 2014-01-23
Q2 2012 13.7M +1.7M +14.2% Jun 30, 2012 10-Q/A 2012-09-20
Q1 2012 12M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 12M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 600K -8.4M -93.3% Sep 30, 2011 10-K/A 2013-03-07
Q2 2011 12M Jun 30, 2011 10-Q 2011-08-11
Q3 2010 9M Sep 30, 2010 10-K 2011-12-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.